BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in the … – Marketwire (press release)
|
BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in the …
Marketwire (press release) BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the … and more |
